TCL Archive European regulators plan more rigorous rules for accelerated approval in cancer. November 11, 2005
TCL Archive Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers May 29, 1981
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm January 31, 1986